Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Lang, Fabian
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Kricheldorf K
,
Döhner K
,
Stegelmann F
,
Jost PJ
,
Lang F
,
Radsak M
,
Hansen R
,
Heuer V
,
Röhrig R
,
Brümmendorf TH
, et al.
Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN.
Leuk Res. 2021;110:106646.
PubMed
Google Scholar
P
Saussele S
,
Haverkamp W
,
Lang F
,
Koschmieder S
,
Kiani A
,
Jentsch-Ullrich K
,
Stegelmann F
,
Pfeifer H
,
La Rosée P
,
Goekbuget N
, et al.
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
Acta Haematol. 2019:1-15.
PubMed
Google Scholar
R
Stelljes M
,
Middeke JMoritz
,
Bug G
,
Wagner-Drouet E-M
,
Müller LP
,
Schmid C
,
Krause SW
,
Bethge W
,
Jost E
,
Platzbecker U
, et al.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Lancet Haematol. 2024.
PubMed
Google Scholar
T
Schubert M-L
,
Schmitt A
,
Hückelhoven-Krauss A
,
Neuber B
,
Kunz A
,
Waldhoff P
,
Vonficht D
,
Yousefian S
,
Jopp-Saile L
,
Wang L
, et al.
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
J Hematol Oncol. 2023;16(1):79.
PubMed
Google Scholar
Cremer A
,
Enssle JC
,
Pfaff S
,
Kouidri K
,
Lang F
,
Brandts C
,
Zeiher A
,
Cremer S
,
Steffen B
,
Serve H
, et al.
Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML.
Ann Hematol. 2023.
PubMed
Google Scholar